M2S Introduces the Analytics and Reporting Engine to the Vascular Quality Initiative®

West Lebanon, NH Sep 14, 2012 – M2S, Inc., the exclusive technology provider for the Society for Vascular Surgery® Vascular Quality Initiative® announces the release of its Analytics and Reporting Engine. This new reporting tool further enhances the value of the VQI® by empowering users to perform complex analyses with just a few mouse clicks.
The Analytics and Reporting Engine sets the VQI apart, providing custom reporting capabilities to give users complete control of their data analysis. Participants of the VQI may now select variables of interest and filter their data set to a desirable patient population for specific analyses. Additionally, users are able to benchmark results with their peers for further comparison of outcomes.
The value of benchmarking improves as VQI participation continues to expand. Today there are 200 centers and over 1,000 physicians collecting data in the VQI. Regional quality groups continue to develop as well and implement quality improvement projects to affect patient care at the local level. The SVS Patient Safety Organization (PSO) plans to accredit eight new regional groups by the end of this year in addition to the ten that are currently organized.
The VQI recently reached another milestone, capturing over 3,500 new procedures each month, making this the fastest growing, validated arterial vascular registry from which to benchmark. The Analytics and Reporting Engine further enhances the control and utility of that data to improve patient care, communicate about the best practices for delivering care with attention to containing costs.

Enhancements to Patriot T.R.I.P. Series

Indianapolis, IN Sep 11, 2012 – International Medical Group®, Inc. (IMG®), a worldwide leader in designing, distributing and administering global health care benefits, announced it enhanced its travel insurance product line, adding to its diverse product portfolio. The Patriot T.R.I.P.® (Travel Itinerary Protection) series of products targets travelers in various markets and provides a wealth of benefits to help protect their vacation investments from costly travel delay, baggage and medical expenses. Insured travelers may also recover non-refundable, unused payments and deposits when a trip is cancelled or interrupted for a variety of reasons.
According to Jeff Nasser, senior vice president of international marketing at IMG, travelers should prepare for the unexpected. “Anything can happen when you travel. Unfortunately, unforeseen events can quickly ruin your travel plans, and that time and money you spent may be lost. These benefits and services are designed to make your trip as stress-free as possible.”
The four programs within the Patriot T.R.I.P. series are underwritten by Sirius America Insurance Company (Sirius America). As a wholly owned subsidiary of Sirius International Insurance Corporation (publ) (Stockholm, Sweden), Sirius America is rated A (Excellent) by A.M. Best. Some of the benefits include:
* Coverage for trip durations to 31 days (options available for longer durations)
* Trip cancellation protection in the event of a stolen passport or visa;
* Trip cancellation protection for work reasons;
* Missed connection coverage;
* Trip cancellation due to a family member’s participation in an athletic championship event; and
* Coverage for theft of mobile business equipment.
Separate from these benefits, the programs provide non-insurance emergency travel assistance, such as helping insureds replace lost travel documents or lost prescriptions, embassy or consulate referral, emergency cash transfers, and legal and medical referrals when necessary.
Mr. Nasser added, “Our goal is to support our customers’ unique needs. By offering a multitude of travel insurance programs that are backed by world-class services, we can help safeguard their travel investments from unforeseen circumstances and provide true Global Peace of Mind®.”

Sparta Systems Named 2012 Software Company of the Year by New Jersey Technology Council

Holmdel, NJ Sep 5, 2012 – Sparta Systems, Inc., the market leader in enterprise quality and compliance management solutions, today announced that it has been named the 2012 Software Company of the Year by the New Jersey Technology Council (NJTC). The award recognizes the Company as a leader among New Jersey technology vendors based on its industry impact, growth rate and success in the marketplace. Sparta will officially receive its honors in Somerset, New Jersey on Thursday, November 15, 2012 during the annual NJTC awards ceremony.
With impressive company growth statistics and accomplishments, Sparta was able to stand out from the competition and receive top billing. Notable successes in the past year include the 450th deployment of TrackWise, the Company’s flagship software product, exceeding 500,000 TrackWise users worldwide, securing the top 30 pharmaceutical companies, eight of the top 10 medical device manufacturers, as well as several leading consumer product and electronic manufacturers as customers.
“With a strategic focus of expanding our company presence and growing our customer base in New Jersey and around the world, this award acknowledges our efforts to be a technology leader in the state, and beyond,” said Eileen Martinson, chief executive officer of Sparta Systems. “This recognition also validates our ability to provide unique and proven enterprise quality management solutions needed to help global organizations deliver their products and services to market, safely and efficiently.”
The New Jersey Tech Council is the leader in connecting companies, capital and governments with technology in the state of New Jersey. Founded in 1996, the NJTC boasts more than 1,000 member companies that are helping to make New Jersey a center for technology leadership and innovation. At the Council’s 16th annual awards gala, New Jersey technology companies and their leaders will be recognized and celebrated for their business accomplishments in technological innovation.
NJTC’s President and CEO, Maxine Ballen couldn’t be more pleased by the tremendous success and growth Sparta Systems has displayed over the recent months. “This is exactly the kind of company New Jersey and the region wants to keep right here. We are thrilled to see Sparta Systems acknowledged and honored for their accomplishments, and we look forward to celebrating with them on November 15th.”
Sparta joins the ranks of past Software Company of the Year winners including, AT&T Solutions, Voxware, RedVision and CyberShift. For more information about the 2012 awards, including details on honorees and sponsors, please visit, http://www.njtc.org/events/gala2012/home.html.

IMG and Asia Medical Assistance Establish PPO Network Agreement

Indianapolis, IN Aug 30, 2012 – IMG Announces New PPO Agreement
International Medical Group®, Inc. (IMG®), a worldwide leader in designing, distributing and administering global health care benefits, announced today that it has entered into an agreement with Asia Medical Assistance (AMA), a division of the Privat Healthcare Group, to provide preferred provider organization (PPO) access to IMG’s insured customers located in the Philippines. The PPO network offers discounted rates and the convenience of direct billing capabilities.
“We are pleased to offer this additional network to our insured customers,” said Jeff Nasser, senior vice president of international marketing at IMG. “This agreement expands and strengthens our network so that customers in this area have access to a wealth of established health care providers. Our new relationship with AMA is another demonstration of our commitment to offer customers the high quality coverage and services they demand.”
With 15 private hospitals and several hundred providers in the Philippines, the AMA PPO enables IMG to provide its customers with more choice, which can help lower claim costs, provide convenient access, reduce out-of-pocket expense, and increase customer satisfaction when they are seeking medical treatment.
“We are honored to be working with IMG,” added Abhijeet Singh Sachdev, CEO of AMA. “This partnership allows us to deliver new options to IMG insureds. We look forward to providing them with high-caliber, cost-effective health care solutions in the Philippines.”
About International Medical Group, Inc. (IMG)
As a leader in the international health insurance market, IMG has provided Global Peace of Mind® to over a million people worldwide in more than 170 countries. For over 20 years, IMG has provided top-tier global medical insurance benefits and has developed a reputation of excellence in the international community. With its around-the-clock medical management services, multilingual claims administrators and highly trained customer service professionals, IMG is confident in its ability to provide the products international travelers need, backed by the services they want. IMG is based in Indianapolis, Indiana USA. Its companies include IMG Europe Ltd, Akeso Care Management®, iTravelInsured®, and IMG-Stop LossSM. IMG’s family of companies is committed to meeting the unique needs of its international clientele.
For more information, call 1.866.368.3724, e-mail info@imglobal.com or visit www.imglobal.com. For additional media information, visit www.imglobal.com/press-kit.
About Asia Medical Assistance (AMA)
As part of the Privat Health Care Group, with over 30 years of experience in the medical field, AMA was built on a strong medical foundation. Privat pioneered travel medical facilitation with the advent of Privat Telemedicine and Privat Travel Clinics in the Asia region.
AMA strives to provide quality ethical health, safety and well-being assistance to those in need. AMA has a formidable clientele of international insurance companies, corporate and government organizations, with partnerships in global networks of medical and travel assistance. For more information, visit www.asiamedassist.org or email info@asiamedassist.org.

Cheryl Robbins Appointed Expert Panelist to AHRQ ICD-10 Workgroup

Wayne, PA and Alpharetta, GA Aug 30, 2012 — Precyse, a leader in Health Information Management (HIM) technology and services, announces that Cheryl Robbins, RHIT,CCS, Precyse director of remote coding operations, will participate as an expert panelist in the Neonatal/Pediatric workgroup on the ICD-10-CM/PCS conversion of Agency for Healthcare Research and Quality (AHRQ) Quality Indicators(QI)™. The research team at University of California Davis, under a federal contract with AHRQ, has the lead role for the conversion process.
These workgroups are being formed as part of a structured approach for converting the existing QI specifications from ICD-9-CM to ICD-10-CM/PCS, incorporating coding expertise, clinical expertise and health services research/quality measurement expertise. The workgroups will evaluate the results of automated “code mapping” from ICD-9-CM to ICD-10-CM/PCS, providing input and advice regarding similarities and differences between ICD-9-CM and ICD-10-CM/PCS codes that are mapped to each other. This workgroup process will lead to recommendations regarding how the existing AHRQ QIs should be re-specified using ICD-10-CM/PCS codes, retaining the original clinical intent of each indicator while taking advantage of the greater specificity of ICD-10-CM/PCS to improve the indicator’s validity.
“I am so honored to participate as a panelist on this ICD-10 workgroup,” said Robbins. “I am excited and ready to contribute my expertise on behalf of the Precyse team, and I am looking forward to making a difference in this thought-leading group.”
Robbins was selected due to her knowledge of health care quality measurement using administrative data in specific, relevant clinical domains, as well as her expertise in ICD-9-CM and ICD-10-CM/PCS coding; hospital quality improvement, patient safety and clinical documentation improvement; and her familiarity with the AHRQ Quality Indicators and their application.

Precyse Open Letter on ICD-10 Final Announcement

Wayne, PA and Alpharetta, GA Aug 29, 2012 — Precyse, a leader in health information management (HIM) technologies and services, leading up to the AHIMA 2012 Annual Conference and Exposition, released the following open letter from Chris Powell, president of Precyse, to all healthcare colleagues regarding the announced ICD-10 final rule. The open letter, answering a critical question at this hour: “How do we reinvigorate our planned ICD-10 implementation roadmaps?” is available below. AHIMA attendees are encouraged to visit Precyse at Booth #236 to continue the ICD-10 conversation.
Healthcare Colleagues,
On August 24, the CMS published a rule finalizing the compliance deadline for converting to the ICD-10 system of diagnostic and procedural coding to Oct. 1, 2014 from Oct. 1, 2013. HHS said the extra time would allow healthcare organizations – especially small organizations – adequate time to get prepare for the changeover.
“By delaying the compliance date of ICD-10 from October 1, 2013, to October 1, 2014, we are allowing more time for covered entities to prepare for the transition to ICD-10 and to conduct thorough testing,” HHS said in the rule. “By allowing more time to prepare, covered entities may be able to avoid costly obstacles that would otherwise emerge while in production.”
Precyse has not stopped preparing for the implementation of the new coding rules and stands ready to support and meet the needs of nearly 1,000 clients – many who rely on our management, staffing and technology solutions – through their training and implementation process. Because Precyse not only supports, but actually operates, entire HIM and coding departments for some of these clients, here are our recommendations:
1. Documentation. Increase your clinical documentation training programs for physicians and other caregivers. You should develop processes, guidance and support for improved clinical documentation under ICD-10. Improved documentation skills – even minor changes such as more specificity in their notes – create obvious financial and non-financial rewards: fewer claims denials, reduced RAC audit exposure, improved case mix index, and improved cash flows. Most important for all of us, patient care is improved when downstream clinicians can review more complete chart notes and better data is available for analytics and comparative studies. Target high volume specialties in your organization most impacted by ICD-10 and train these specialists in proper documentation while training the coding team on accurate coding; then, move to the next specialty for training.
2. Training and Development. Act now to invest in the training of your coders AND those who will use
the data. Improve the basic skills of your coders in ICD-9 areas that will also be required in ICD-10. The transition to ICD-10 has pushed healthcare to appropriately invest in training our coders as skilled knowledge workers. As part of our own ICD-10 preparations, Precyse assessed the coding skills of nearly 300 coders on our staff to evaluate their ICD-10 readiness. We found additional training needs related to anatomy, physiology and pathopharmacology, as well as opportunities to improve their understanding of coding system logic and principles. So Precyse invested in and developed a comprehensive and multifaceted training program that can be delivered via virtual webinars and our online Precyse University, while developing individual training plans for every coder. This investment has paid off for Precyse clients handsomely, yielding a better case mix index for hospitals, improved coding compliance audit results, increased coder retention, and attracting new coder recruits who are eager to develop and perfect their skills. So we recommend that you perform side-by-side ICD-9 and ICD-10 coding, assessing the documentation and coding gaps and target training based on these findings.
3. Build a strong foundation for process improvement. Assess the flow of your information across your organization and develop a plan to address gaps through process improvement and technology. Invest in automated systems that streamline the entire clinical documentation process. ICD-10 was never just about re-training medical coders–it was and is about having better data about patients and their treatments, affording vast opportunities for improvement in how data are captured and processed. This leads to a more complete and useful set of codes, which is crucial in a fully automated electronic medical record environment. Today, inefficient, labor-intensive workflows abound, whether involving clinical information inputs such as dictation and transcription; service approvals, coding, physician queries, and other myriad facets involved in billing for services; or abstracting and analyzing quality indicators to improve patient care. We also recognize the promise of future innovations such as automated speech recognition, Computer Assisted Coding using Natural Language Comprehension™ (NLC), and clinical decision support tools – but know that realizing their full promise tomorrow requires that we improve how current users interact with and use their systems today. Those of us in the health care information management/information technology community must use our skills to innovate for clinicians. We must develop workflow platforms and applications that allow health care providers to do their jobs more efficiently and effectively. We do not want to add more time and complexity to an already burdensome process.
At Precyse, our vision is a world in which meaningful information is available, whenever and wherever needed, and this information helps save time, money and lives. We are an innovation company that listens carefully to our clients and prospects; every day we challenge ourselves to come back to these clients with solutions that solve their business problems while improving patient care and outcomes. We pledge to our clients and future prospects that we will never stop innovating in the midst of very challenging times.

Precyse Appoints Three Industry Leaders to Key Positions

Wayne, PA and Alpharetta, GA Aug 2, 2012 — Precyse, a leader in health information management (HIM) technologies and services, announces the appointment of three industry leaders to influential positions targeted at supporting clients with their ICD-10 strategies and beyond. James H. Crook, Jr., a veteran of the healthcare software and services industry, has been appointed to the Precyse Advisory Council (PAC). Chris Skiffington, a proven leader in healthcare technology sales, has joined Precyse as Senior Vice President and
National Sales Manager. Debra Stenner, a market-winning healthcare IT product development and strategy expert, has joined the company as Vice President of Business Planning and Product Strategy.
Crook brings more than 30 years of experience to the Precyse Advisory Council, which functions as a source of high-level input and advice on the strategic positioning and expansion of Precyse’s service and technology offerings. The PAC also serves as a conduit for new business opportunities because of the extensive experience and networks developed by each of the council members.
“We are delighted to welcome Jim to the Precyse Advisory Council,” said Precyse CEO Jeffrey Levitt. “His deep healthcare IT experience will provide an invaluable contribution as Precyse strives to offer the HIM industry the technology necessary for the completion of strategic initiatives such as EHR, Meaningful Use, ICD-10 and other initiatives.”
As Senior Vice President and National Sales Manager, Chris Skiffington will lead the Precyse sales organization as it focuses on existing and new client sales, as well as a solution expertise. A member of the Precyse Executive Leadership Team, Skiffington will report directly to Chris Powell, president, and will be based in the company’s corporate office in Wayne.
“Chris brings tremendous expertise in healthcare, technology and sales management to his role,” said Powell. “His background in enterprise selling is well-positioned to ensure that Precyse is front and center nationally.”
In her role as Vice President of Business Planning and Product Strategy, Debra Stenner will lead Precyse’s strategic product management functions.
“Debra’s role is fundamental to our success as a true innovation company,” said Powell. “She is committed to working with our hospital and physician practice clients to find innovative ways to improve productivity, quality and accuracy, streamline processes and increase revenue.”
James H. Crook, Jr., Precyse Advisory Council Member
Crook recently retired as Chief Executive Officer of IDX Systems Corporation, a leading provider of software and services to the healthcare industry. He was responsible for all aspects of the IDX business, including overseeing relationships with customers at over 3,400 healthcare organizations and 2,400 employees working in 10 locations throughout the United States and the United Kingdom. Crook had previously served as President and Chief Operating Officer of IDX, during which time he oversaw the restructuring of the company and the implementation of a newly aligned Operating Unit model. He holds a bachelor of arts degree in Administrative Science from Colby College in Waterville, Maine.
Chris Skiffington, Senior Vice President, National Sales Manager, Precyse
Prior to joining Precyse, Skiffington led the Southeast Zone for GE Healthcare HCIT division and was responsible for the P&L’s performance across the portfolio in Alabama, Florida, Georgia, Tennessee, Louisiana, Mississippi, North Carolina and South Carolina. Prior to that, Skiffington was employed for 10 years at IBM, where he was responsible for leading and managing a 162-person, $500 million sales business and achieved award-winning sales performance year after year. He also had served as the Regional Sales Manager and Senior Sales Professional, as well as a Software Account Manager. Skiffington holds an MBA from Boston College and a bachelor of science degree in business management from Westfield State University.
Debra Stenner, Vice President of Business Planning and Product Strategy, Precyse
Stenner has more than 25 years of industry experience. She most recently was principal of Four Winds Consulting, where she aided clients in establishing go-forward product strategies and new product commercialization. She previously was vice president of business planning and product strategy, Imagecast Division, for IDX Systems Corp. She also served as a member of the Integrating the Healthcare Enterprise (IHE) initiative, a joint initiative of the Radiology Society of North America (RSNA) and the Health Information Management Systems Society (HIMSS). A graduate of the University of Wisconsin in Platteville, Stenner holds a BS in medical technology. She continues to publish healthcare technology and life sciences articles and to present at a variety of industry events.

Kerasal® Launch in Canada Progresses at Major Drug Chains and Walmart Supercenters

Cedar Knolls, NJ July 10, 2012 – Alterna LLC, makers of Kerasal®, is progressing with its launch in Canada. The Canadian launch initiated in March of this year with the listing of two Kerasal SKUs at Shoppers Drug Mart and Pharmaprix stores. In recent months, Kerasal has added distribution in most Walmart stores, Jean Coutu, Uniprix, and other chains.
Kerasal is an iconic brand in foot care, with US distribution in all major chains and Walmart. Kerasal One Step Exfoliating Moisturizing Foot Ointment is the non-prescription brand most often recommended by U.S. podiatrists for softening severely dry feet. In addition to Kerasal One Step, Kerasal ultra20 Moisturizer Daytime Therapy Foot Softening Cream is available in Canada. Kerasal ultra20 is absorbed quickly by the skin, so it is perfect for daytime use.
“Canadian consumers, like our US customers, are savvy,” says Don Carswell, Director of International Sales at Alterna. “They want a product that is fast, effective and clinically proven. Kerasal One Step exfoliates and moisturizes the skin of the feet in a single step, which saves time and increases efficacy giving consumers softer feet faster.” Mr. Carswell noted that the Kerasal One Step Foot Ointment has been awarded the seal of approval by the Canadian Podiatric Medical Association.
Alterna is supporting the launch in Canada with national television advertising with English and French versions of its new television commercial. In addition to consumer support, Kerasal samples are being distributed to over 100 Canadian podiatrists who have requested samples. Alterna LLC, the US-based maker of Kerasal, has teamed up with Associated National Brokerage, Inc., of Newmarket, Ontario to serve its customers in Canada. Alterna plans to bring additional products to the Canadian market in the near future.

HealthTech Solutions Group® Promotes Brian Montfort to Vice President of Software Development

Plano, TX Jul 20, 2012 – Brian Montfort has been promoted to vice president of software development at HealthTech Solutions Group®, a leading provider of cloud-based revenue cycle management solutions.
“Brian’s expertise has been instrumental in the development and expansion of our breakthrough, cloud-based receivables management platform, myCLAIMIQ AlphaCollector™,” said Derek Morkel, chief executive officer at HealthTech. “His knowledge and experience will continue to lead our talented team of technology professionals while supporting our company vision.”
Since joining HealthTech Solutions Group in 2010, Montfort had held the position of senior software engineer, focusing on the development of new revenue cycle software solutions. He also was responsible for providing implementation and technical guidance to hospitals accessing the company’s proprietary software.
“The incredible reception that we have had to myCLAIMIQ AlphaCollector™ and the exciting pipeline of new software developments is a direct result of the work from Brian and his team,” said Morkel. “We are extremely excited at the possibilities as we extend the functionality of our integrated, cloud-based platform to new areas of the revenue cycle.”

Alterna LLC Expands Kerasal® Brand’s Distribution

Cedar Knolls, NJ Jul 10, 2012 – Alterna LLC, makers of Kerasal® and Kerasal® Nail™, today announced that Kerasal Foot Ointment, already sold in approximately 3,200 Walmart stores, will be available in all 3,871 Walmart stores in late August. Kerasal Foot Ointment is the #1 one podiatrist recommended mass distributed non-prescription foot softener for severely dry feet, and has been sold in food, drug, and mass retail stores for over 8 years.
As a result of its successful launch this past year, Alterna’s newest product – Kerasal Nail Fungal Nail Renewal Treatment – will also expand its distribution at the world’s largest mass retailer from approximately, 1,300 stores to over 3,500 stores. Kerasal Nail is a clinically proven topical formula for rapidly improving the appearance of nails damaged by fungus or psoriasis. It is the only nail penetrating formula on the market with multiple clinical studies showing clinical signs of improvement in just two weeks. Alterna holds the exclusive license in the United States for the patented formula, developed by Moberg Derma AB.
Kerasal and Kerasal Nail are widely distributed, and also available at leading drug chains including Walgreens, CVS, and Rite Aid. Fueled by a multi-million dollar television and print advertising campaign, the Kerasal brand has experienced double digit retail sales growth over the last 52 weeks for 52 weeks ending May 13, 2012, according to data reported by IRI.